2012
DOI: 10.1001/2013.jamainternmed.111
|View full text |Cite
|
Sign up to set email alerts
|

Lactobacilli vs Antibiotics to Prevent Recurrent Urinary Tract Infections: An Inconclusive, Not Inferior, Outcome—Reply

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
4
0
3

Year Published

2015
2015
2023
2023

Publication Types

Select...
6
2

Relationship

0
8

Authors

Journals

citations
Cited by 11 publications
(7 citation statements)
references
References 2 publications
0
4
0
3
Order By: Relevance
“…The drive for using newer technologies is to gain a better understanding of what microorganisms are doing at particular sites. In the lower urogenital tract, such as at the vagina, we know that certain bacteria are in fact sentinels and protectors against potentially deleterious microorganisms that may ascend and cause problems such as UTI (8,9). We do not truly understand if or how the microbiome plays a protective role in the bladder, but we assume that the lower urogenital tract is the gateway to this region.…”
Section: What Is the Microbiome Doing In The Urinary System?mentioning
confidence: 98%
“…The drive for using newer technologies is to gain a better understanding of what microorganisms are doing at particular sites. In the lower urogenital tract, such as at the vagina, we know that certain bacteria are in fact sentinels and protectors against potentially deleterious microorganisms that may ascend and cause problems such as UTI (8,9). We do not truly understand if or how the microbiome plays a protective role in the bladder, but we assume that the lower urogenital tract is the gateway to this region.…”
Section: What Is the Microbiome Doing In The Urinary System?mentioning
confidence: 98%
“…Otros estudios realizados para evaluar la eficacia de estos probióticos en la prevención de las infecciones urinarias, como el de Beerepoot et al, en el que se compara el uso de TMP-SMX 480 mg cada 24 horas y el de cápsulas orales con 109 UFC de Lactobacillus rhamnosus GR-1 y Lactobacillus reuteri RC-14 dos veces al día en mujeres postmenopáusicas, no han demostrado la eficacia esperada por los agentes probióticos (se reflejó por lo menos un episodio de ITU en un 69,3% de las pacientes del grupo TMP-SMX y en un 79,1% del grupo de Lactobacillus, con una media de 6 y 3 respectivamente hasta la aparición de síntomas) [226]. Sin embargo, sí que pueden tener un papel coadyuvante al administrarlo con antibióticos para la destrucción de los biofilms bacterianos [227].…”
Section: Profilaxis Con Probióticosunclassified
“…Different approaches have been proposed, including the use of probiotic lactobacillus, functional foods, and vaccines [9]. Although promising, existing data for prevention of UTI using lactobacillus are to date insufficient and await further validation [17,18].…”
mentioning
confidence: 99%